Ana sayfa
/
Biyoloji
/
has of planna memberane integrity and swelling of the cell body followed by death). ancuploidy due to non -dinjunction in sex a direct genotoxic carcitogen. so FDA classification of drug risk (as a possible teratogen) during promancy Thalidomide is in the X category. Which of the following base-pair mutations is property characterized as a Chasvension mutation? a) Tarrow C b) Aarrow G G- A. (1) Tarrow U Aarrow C (Lon) 12. What are the 2 important factors for the CYPs to canalyse the oxidation reactions? ANADPILIH + NADPH-eylochrome P450 b) NADH,II +Phospholipids NADPH_(3)H+O_(2) (4) O_(2).Phospbolipid c) CO+NADH,H (1.07) 13. Whish one of the following CYP is not expressed in human liver? a) CYP2C9 b) CYP3A4 c) CYP2D6 d) CYPIAI c) CYP2B6 14. Adaptation of toxicity may result from biological changes causing the below processes with the exception of one Which of the following statement ks EALSE 7 a)Diminisbed delivery of the toxicant to thetarget. b) Decrease DNA repair capacity. c) Issreased capacity of the organism to repair itself. d) Strengthened mechnisms to compensate the toxicant caused dysfunction. e) Decreased size or susceptibility of the target. (109) 15. Which of the following is not among the primary metabolic disorders jespardizing cell survival? a)ATP depletion b) Sustained rise in intracellular Ca2+ c) Overproduction of ROS, d) Overproduction of RMS e)Increase cytosolic Glutathione level (LO9) 16. Which of the following agent that does not impair ATP synthesis? a)Rotenone b) Paracetamol c)Paraquat d)DDT e)Cyanide

Soru

has of planna memberane integrity and swelling of the cell body followed by
death).
ancuploidy due to non -dinjunction in sex
a direct genotoxic carcitogen.
so FDA classification of drug risk (as a possible teratogen) during
promancy Thalidomide is in the X category.
Which of the following base-pair mutations is property characterized as a
Chasvension mutation?
a) Tarrow C b) Aarrow G G- A. (1) Tarrow U Aarrow C
(Lon) 12. What are the 2 important factors for the CYPs to canalyse the oxidation reactions?
ANADPILIH + NADPH-eylochrome P450	b) NADH,II +Phospholipids
NADPH_(3)H+O_(2) (4) O_(2).Phospbolipid c) CO+NADH,H
(1.07) 13. Whish one of the following CYP is not expressed in human liver?
a) CYP2C9 b) CYP3A4 c) CYP2D6 d) CYPIAI c) CYP2B6
14. Adaptation of toxicity may result from biological changes causing the below
processes with the exception of one Which of the following statement ks
EALSE 7
a)Diminisbed delivery of the toxicant to thetarget.
b) Decrease DNA repair capacity.
c) Issreased capacity of the organism to repair itself.
d) Strengthened mechnisms to compensate the toxicant caused dysfunction.
e) Decreased size or susceptibility of the target.
(109)
15. Which of the following is not among the primary metabolic disorders jespardizing
cell survival?
a)ATP depletion b) Sustained rise in intracellular
Ca2+ c) Overproduction of ROS,
d) Overproduction of RMS e)Increase cytosolic Glutathione level
(LO9)
16. Which of the following agent that does not impair ATP synthesis?
a)Rotenone b) Paracetamol c)Paraquat d)DDT e)Cyanide

has of planna memberane integrity and swelling of the cell body followed by death). ancuploidy due to non -dinjunction in sex a direct genotoxic carcitogen. so FDA classification of drug risk (as a possible teratogen) during promancy Thalidomide is in the X category. Which of the following base-pair mutations is property characterized as a Chasvension mutation? a) Tarrow C b) Aarrow G G- A. (1) Tarrow U Aarrow C (Lon) 12. What are the 2 important factors for the CYPs to canalyse the oxidation reactions? ANADPILIH + NADPH-eylochrome P450 b) NADH,II +Phospholipids NADPH_(3)H+O_(2) (4) O_(2).Phospbolipid c) CO+NADH,H (1.07) 13. Whish one of the following CYP is not expressed in human liver? a) CYP2C9 b) CYP3A4 c) CYP2D6 d) CYPIAI c) CYP2B6 14. Adaptation of toxicity may result from biological changes causing the below processes with the exception of one Which of the following statement ks EALSE 7 a)Diminisbed delivery of the toxicant to thetarget. b) Decrease DNA repair capacity. c) Issreased capacity of the organism to repair itself. d) Strengthened mechnisms to compensate the toxicant caused dysfunction. e) Decreased size or susceptibility of the target. (109) 15. Which of the following is not among the primary metabolic disorders jespardizing cell survival? a)ATP depletion b) Sustained rise in intracellular Ca2+ c) Overproduction of ROS, d) Overproduction of RMS e)Increase cytosolic Glutathione level (LO9) 16. Which of the following agent that does not impair ATP synthesis? a)Rotenone b) Paracetamol c)Paraquat d)DDT e)Cyanide

Çözüm

4.6284 Voting
avatar
Yelda
Uzman · 3 yıl öğretmeni
Uzman doğrulaması

Cevap

Let's go through each question and provide the correct answers:<br /><br />1. **Thalidomide is in the X category.**<br /> - **Answer:** X category<br /><br />2. **Which of the following base-pair mutations is properly characterized as a transition mutation?**<br /> - **Answer:** a) $T\rightarrow C$<br /><br />3. **What are the 2 important factors for the CYPs to catalyze the oxidation reactions?**<br /> - **Answer:** a) NADPH + O2<br /><br />4. **Which one of the following CYP is not expressed in human liver?**<br /> - **Answer:** d) CYP1AI<br /><br />5. **Adaptation of toxicity may result from biological changes causing the below processes with the exception of one. Which of the following statement is FALSE?**<br /> - **Answer:** c) Increased capacity of the organism to repair itself.<br /><br />6. **Which of the following is not among the primary metabolic disorders jeopardizing cell survival?**<br /> - **Answer:** e) Increase cytosolic Glutathione level<br /><br />7. **Which of the following agent does not impair ATP synthesis?**<br /> - **Answer:** b) Paracetamol
Derecelendirmek için tıklayın: